Multiple people are in the hospital after being ejected from their vehicle in yet another crash on Powers Boulevard last ...
CAR T-cell therapy is a type of immunotherapy used to treat multiple myeloma when other therapies have failed. It has improved remission and survival times, but long-term data on safety and success is ...
Multiple people were thrown from a car and injured on Tuesday, Dec. 30, when their car collided with another at the ...
A hallmark characteristic of CAR T therapy is that it is individually crafted. Each patient receives a unique cancer-fighting infusion made from their own immune cells. The crucial process of ...
Two children were killed and over a dozen people were injured after a driver crashed into a Michigan boat club where a birthday party was taking place, authorities say. The incident took place at Swan ...
Jacksonville Journal-Courier on MSN
Beardstown man accused of ramming car multiple times, faces DUI, battery charges
Police arrested a 24-year-old man accused of intentionally ramming a car three times on aggravated battery and other charges.
WISH-TV on MSN
Multiple kids lead Terre Haute police, county deputies on high-speed chase in stolen car
Multiple juveniles face charges after leading police on a high-speed chase in a stolen car in Terre Haute, Indiana.
Please provide your email address to receive an email when new articles are posted on . Although chimeric antigen receptor T-cell therapy is approved for treatment of multiple myeloma, commercially ...
A "living drug," CAR T involves removing cells from the body, modifying them, and finally reinfusing them into the body to fight cancer. This is the third installment in a series on the advances CAR T ...
Wiring in one amplifier can be complicated enough, especially when dealing with a factory car stereo. The situation gets more complex when you add multiple amplifiers to the equation. You can wire two ...
Patients with multiple myeloma treated with idecabtagene vicleucel, known as "ide-cel," a chimeric antigen receptor (CAR) T-cell therapy, had no difference in overall survival outcomes regardless of ...
Multiple myeloma highlights from ASH 2025 include two late-breaking abstracts, a phase 2 trial on a novel CAR T-cell therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback